Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Lower-income Patients are less likely to participate in clinical trials

2012 ASCO Annual Meeting

Published: 3 Jun 2012

Views: 4335

Rating:

Save

Dr Joseph Unger - SWOG Statistical Center, Seattle, USA

At a press conference during the ASCO 2012 Annual Meeting in Chicago, June 1st - June 4th, Dr Joseph Unger presented data from a national survey of cancer patients showing that income strongly predicts the likelihood a patient will participate in a clinical trial, which raises concern that lower-income patients don’t have equal access to clinical trials.

ecancerNews Coverage

Related Videos

Prostate cancer

Dr Alison Tree - Institute of Cancer Research, London, UK

Prostate cancer ( Dr Alison Tree - Institute of Cancer Research, London, UK )

Enhancing cancer management: The role of oncology pharmacists in Kenya

Dr Waithira Irene Weru - Kenyatta National Hospital, Nairobi, Kenya

Enhancing cancer management: The role of oncology pharmacists in Kenya ( Dr Waithira Irene Weru - Kenyatta National Hospital, Nairobi, Kenya )

Gaza's cancer patients: Navigating the dual struggle of illness and war

Dr Ru'a Rimawi - Dana-Farber Cancer Institute, Boston, United States of America

Gaza's cancer patients: Navigating the dual struggle of illness and war ( Dr Ru'a Rimawi - Dana-Farber Cancer Institute, Boston, United States of America )

Cancer in emergencies: What can we do better to protect the most vulnerable?

Prof Tezer Kutluk - Turkish Association for Cancer Research and Control, Ankara, Turkey

Cancer in emergencies: What can we do better to protect the most vulnerable? ( Prof Tezer Kutluk - Turkish Association for Cancer Research and Control, Ankara, Turkey )

Navigating cancer treatment choices

Dr Shriniwas Kulkarni - Sahyadri Superspeciality Hospital,Pune, India

Navigating cancer treatment choices ( Dr Shriniwas Kulkarni - Sahyadri Superspeciality Hospital,Pune, India )

Advancements in head and neck cancer treatment in India

Dr Amol Akhade - Tata Memorial Hospital, Mumbai, India

Advancements in head and neck cancer treatment in India ( Dr Amol Akhade - Tata Memorial Hospital, Mumbai, India )

Enhancing head and neck oncology: Key insights from the conference

Dr Anil D'Cruz - Apollo Hospitals, Mumbai, India

Enhancing head and neck oncology: Key insights from the conference ( Dr Anil D'Cruz - Apollo Hospitals, Mumbai, India )

Multiple myeloma treatment in Dakar: Epidemiological, diagnostic, and therapeutic aspects

Dr Nata Dieng - Hôpital Principal de Dakar, Dakar, Senegal

Multiple myeloma treatment in Dakar: Epidemiological, diagnostic, and therapeutic aspects ( Dr Nata Dieng - Hôpital Principal de Dakar, Dakar, Senegal )

TARGeted IORT INTRABEAM is a useful treatment option for early stage breast cancer

Dr Elena Sperk - Universitätsmedizin Mannheim, Mannheim, German

TARGeted IORT INTRABEAM is a useful treatment option for early stage breast cancer ( Dr Elena Sperk - Universitätsmedizin Mannheim, Mannheim, German )

More from ecancer